期刊文献+

卡马西平、奥卡西平相关尿潴留 被引量:3

Urinary retention associated with carbamazepine as well as oxcarbazepine
原文传递
导出
摘要 1例72岁女性患者,因带状疱疹后遗神经痛服用卡马西平0.1 g、2次/d,1 d后出现尿潴留,停药并予导尿术治疗后恢复正常。停用卡马西平后4 d,患者服用奥卡西平0.3 g、2次/d,次日再次出现尿潴留、排尿困难,停用奥卡西平,留置导尿管并给予抗感染治疗,7 d后排尿恢复正常。 A 72-year-old female patient received carbamazepine 0.1 g twice daily for postherpetic neuralgia. One day later, she experienced retention of urine. The drug was discontinued and, after catheterization therapy, she could urinate normally. Four clays after carbamazepine discontinuation, the patient received oxcarbazepine 0.3 g twice daily. The next day, she redeveloped urinary retention and dysuria. Then oxcarbazepine was stopped. Retention catheterization and anti-infective therapy were given. Seven days later, the patient urinated normally.
出处 《药物不良反应杂志》 2012年第2期122-123,共2页 Adverse Drug Reactions Journal
关键词 卡马西平 尿潴留 奥卡西平 carbamazepine urinary retention oxcarbazepine
  • 相关文献

参考文献9

  • 1王海叶,段金菊.一例卡马西平引起复视 尿潴留患者的药学监护[J].中国药物与临床,2010,10(2):236-236. 被引量:8
  • 2孙健,刘朋,傅得兴,刘治军.卡马西平致排尿困难[J].药物不良反应杂志,2011,13(2):121-122. 被引量:4
  • 3Hmouda H, Ben Salem C, Grira M, et al. Carbamazepine-induced urinary retention[ J]. Br J Clin Phamaacol, 2007, 64 (6) : 833-834.
  • 4Steiner I, Birmanns B. Carbamazepine-indueed urinary retention in long-standing diabetes mellitus [ J ]. Neurology, 1993, 43 (9) : 1855-1856.
  • 5Filling-Katz MR, Merrick HF, Fink JK, et al. Carbamazepine in Fabry disease:efective an algesia with dose-dependent exacerbation of autonomic dysfunction[J]. Neurology, 1989, 39(4): 598-600.
  • 6Hegde SS. Muscarinic receptors in the bladder: from basic research to therapeutics[Jl. Br J Pharmacol, 2006, 147(Suppl 2) : S80-S87.
  • 7Yoshimura N, Chancellor MB. Differential diagnosis and treatment of impaired bladder emptying [ J ]. Rev Urol, 2004, 6 ( Suppl ) : S24-S31.
  • 8李家泰.临床药理学[M].北京:人民卫生出版社,2007.
  • 9喻东山.奥卡西平临床应用的安全性[J].药物不良反应杂志,2007,9(2):105-107. 被引量:20

二级参考文献24

  • 1王湘庆,郎森阳.新型抗癫痫药物对认知功能的影响[J].海军总医院学报,2006,19(1):26-29. 被引量:7
  • 2江帆.美国的奥卡西平说明书中增加新的警告[J].中国药师,2006,9(6):571-571. 被引量:4
  • 3姬玉萍,张艳.卡马西平的不良反应[J].四川精神卫生,2007,20(1). 被引量:4
  • 4Hmouda H,Ben Salem C,Grira M,et al.Carbamazepine-induced urinary retention[J].Br J Clin Pharmacol,2007,64(6):833-834.
  • 5Steiner I,Birmanns B.Carbamazepine-induced urinary retention in long-standing diabetes mellitus[J].Neurology,1993,43(9):1855-1856.
  • 6Filling-Katz MR,Merriek HF,Fink JK,et al.Carbamazepine in Fabry's disease:effective analgesia with dose-de-pendent exacerbation of autonomic dysfunetion[J].Neurology,1989,39(4):598-600.
  • 7Hedge SS.Muscarinic receptors in the bladder:from basic research to therapeutics[J].Br J Pharmacol,2006,147:S80-87.
  • 8Yoshimura N,Chancellor MB.et al.Differential diagnosis and treatment of impaired bladder emptying[J].Rev Urol,2004,6(Suppl.):S24-S31.
  • 9Christensen J, Sabers A, Sidenius P. Oxcarbazepine concentrations during pregency: a retrospective study in patients with epileps [J]. Neurology, 2006, 67 (9): 1497-1499.
  • 10Waldmeier PC, Baumarm PA, Wicki P, et al. Similer potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters[J]. Neurology, 1995, 45 (10): 1907-1913.

共引文献44

同被引文献43

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部